These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27591250)

  • 1. A stochastic model for the normal tissue complication probability (NTCP) and applicationss.
    Stocks T; Hillen T; Gong J; Burger M
    Math Med Biol; 2017 Dec; 34(4):469-492. PubMed ID: 27591250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
    Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
    Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-passage times and normal tissue complication probabilities in the limit of large populations.
    Hufton PG; Buckingham-Jeffery E; Galla T
    Sci Rep; 2020 May; 10(1):8786. PubMed ID: 32472002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical note: calculation of normal tissue complication probability using Gaussian error function model.
    Chow JC; Markel D; Jiang R
    Med Phys; 2010 Sep; 37(9):4924-9. PubMed ID: 20964211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposals of models for new formulations of the current complication-free cure (P+) and uncomplicated tumor control probability (UTCP) concepts, and total normal tissue complication probability of late complications.
    Frometa-Castillo T; Pyakuryal A; Wals-Zurita A; Mesbahi A
    Int J Radiat Biol; 2020 Jul; 96(7):847-850. PubMed ID: 32163306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to visualize the uncertainty of the prediction of radiobiological models.
    Zhang L; Hub M; Thieke C; Floca RO; Karger CP
    Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model.
    Kehwar TS
    J Cancer Res Ther; 2005; 1(3):168-79. PubMed ID: 17998649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
    Paganetti H
    Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal tissue complication probability (NTCP) models for modern radiation therapy.
    Palma G; Monti S; Conson M; Pacelli R; Cella L
    Semin Oncol; 2019 Jun; 46(3):210-218. PubMed ID: 31506196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stochastic model for tumour control probability that accounts for repair from sublethal damage.
    Ponce Bobadilla AV; Maini PK; Byrne H
    Math Med Biol; 2018 Jun; 35(2):181-202. PubMed ID: 28339783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Kim Y; Tomé WA
    Med Biol Eng Comput; 2007 Nov; 45(11):1045-51. PubMed ID: 17574487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.
    Song W; Schaly B; Bauman G; Battista J; Van Dyk J
    Med Phys; 2005 Jul; 32(7Part1):2193-2203. PubMed ID: 28493587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.
    Nutting CM; Corbishley CM; Sanchez-Nieto B; Cosgrove VP; Webb S; Dearnaley DP
    Br J Radiol; 2002 Feb; 75(890):151-61. PubMed ID: 11893639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy.
    Sánchez-Nieto B; Romero-Expósito M; Terrón JA; Sánchez-Doblado F
    Phys Med; 2017 Oct; 42():277-284. PubMed ID: 28392313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Random forests to predict rectal toxicity following prostate cancer radiation therapy.
    Ospina JD; Zhu J; Chira C; Bossi A; Delobel JB; Beckendorf V; Dubray B; Lagrange JL; Correa JC; Simon A; Acosta O; de Crevoisier R
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1024-1031. PubMed ID: 25035205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-consistent tumor control probability and normal tissue complication probability models based on generalized EUD.
    Zhou SM; Das SK; Wang Z; Sun X; Dewhirst M; Yin FF; Marks LB
    Med Phys; 2007 Jul; 34(7):2807-15. PubMed ID: 17821988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the effect of marked normal structure volume on normal tissue complication probability.
    Hornby CJ; Ackerly T; See A; Geso M
    Med Dosim; 2003; 28(4):223-7. PubMed ID: 14684186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.